Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,353.61
(
-0.67%
)
US TECH 100
28,118.00
(
-0.42%
)
Dow Jones
49,363.88
(
-0.65%
)
Brent Oil
107.59
(
-0.14%
)
Bitcoin
76,630.38
(
-0.15%
)
News Focus
News Focus
Post# of 826878
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

dennisdave

Send PM Follow Ignore
Followers 42
Posts 5340
Boards Moderated 0
Alias Born 12/05/2021

dennisdave

Re: Galzus Research post# 767525

Tuesday, 05/13/2025 2:10:22 PM

Tuesday, May 13, 2025 2:10:22 PM

Post# of 826878

why switch the primary endpoint

you really are thick as shit. 40% of all medical trials switch endpoints, for example, Anavex switched endpoints after they locked data (which is legal). Switching endpoints is perfectly normal and legal. You are biotech clueless
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News